Pancreatic Cancer Research

ResearcherLeiden University Medical CenterActive in the last 2 years

Rob C. Hoeben

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9443-8377; OpenAlex author ID A5005383720. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers

Papers 3

  1. Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma. Last author DOI 10.1002/1878-0261.13561↗
  2. Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures. Co-author DOI 10.1016/j.ebiom.2024.105219↗
  3. Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus 'GoraVir' in Cultured Pancreatic Cancer Cells. Last author DOI 10.3390/v15020283↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Selas T. F. Bots · 3 shared papers, 2023–2024 · strength 0.62
  2. Vera Kemp · 2 shared papers, 2024 · strength 0.39
  3. Tom J. Harryvan · 1 shared paper, 2024 · strength 0.24
  4. Florian Gebauer · 1 shared paper, 2024 · strength 0.15
  5. Christine E. Engeland · 1 shared paper, 2024 · strength 0.15
  6. Claudia R. Ball · 1 shared paper, 2024 · strength 0.15
  7. Lukas J.A.C. Hawinkels · 1 shared paper, 2024 · strength 0.15
  8. Guy Ungerechts · 1 shared paper, 2024 · strength 0.15
  9. Theresa E. Schäfer · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.